Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic potential of interleukin-2 in autoimmune diseases
Yeshuang Yuan, Antonios G.A. Kolios, Yudong Liu, et al.
Trends in Molecular Medicine (2022) Vol. 28, Iss. 7, pp. 596-612
Closed Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

T cells in health and disease
Lina Sun, Yanhong Su, Anjun Jiao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 359
RNA modifications: importance in immune cell biology and related diseases
Lian Cui, Rui Ma, Jiangluyi Cai, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 197
Abnormalities of T cells in systemic lupus erythematosus: new insights in pathogenesis and therapeutic strategies
Hao Li, Afroditi Boulougoura, Yushiro Endo, et al.
Journal of Autoimmunity (2022) Vol. 132, pp. 102870-102870
Open Access | Times Cited: 110
Gluconolactone restores immune regulation and alleviates skin inflammation in lupus-prone mice and in patients with cutaneous lupus
Wei Li, Antonios G.A. Kolios, Wenliang Pan, et al.
Science Translational Medicine (2025) Vol. 17, Iss. 786
Closed Access | Times Cited: 2
Reigniting hope in cancer treatment: the promise and pitfalls of IL-2 and IL-2R targeting strategies
Shan Muhammad, Tao Fan, Yang Hai, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 41
Proximity-enabled covalent binding of IL-2 to IL-2Rα selectively activates regulatory T cells and suppresses autoimmunity
Bo Zhang, Jiaqi Sun, Yeshuang Yuan, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 29
The path to next-generation disease-modifying immunomodulatory combination therapies in Alzheimer’s disease
Marie Sarazin, Julien Lagarde, I. Haddad, et al.
Nature Aging (2024) Vol. 4, Iss. 6, pp. 761-770
Closed Access | Times Cited: 12
Biospecific Chemistry for Covalent Linking of Biomacromolecules
Li Cao, Lei Wang
Chemical Reviews (2024) Vol. 124, Iss. 13, pp. 8516-8549
Open Access | Times Cited: 11
A humanized IL-2 mutein expands Tregs and prolongs transplant survival in preclinical models
Orhan Efe, Rodrigo Benedetti Gassen, Leela Morená, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 5
Open Access | Times Cited: 9
Systemic lupus erythematosus-complicating immune thrombocytopenia: From pathogenesis to treatment
Ying Jiang, Yongjing Cheng, Shiliang Ma, et al.
Journal of Autoimmunity (2022) Vol. 132, pp. 102887-102887
Closed Access | Times Cited: 38
Innovative strategies for the discovery of new drugs against alopecia areata: taking aim at the immune system
Hongwei Guo, Zhiming Ye, Siqi Chen, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 11, pp. 1321-1338
Closed Access | Times Cited: 5
Mechanistic insight into premature atherosclerosis and cardiovascular complications in systemic lupus erythematosus
Yudong Liu, Xue Yu, Wenduo Zhang, et al.
Journal of Autoimmunity (2022) Vol. 132, pp. 102863-102863
Closed Access | Times Cited: 22
The effect of Sichuan pepper on gut microbiota in mice fed a high-sucrose and low-dietary fibre diet
Yumeng Xia, Takashi Kuda, Mahiro Yamamoto, et al.
Applied Microbiology and Biotechnology (2023) Vol. 107, Iss. 7-8, pp. 2627-2638
Closed Access | Times Cited: 12
Low-dose IL-2 therapy in autoimmune diseases: An update review
Ruizhi Zhang, Yuyang Zhao, Xiangming Chen, et al.
International Reviews of Immunology (2023) Vol. 43, Iss. 3, pp. 113-137
Closed Access | Times Cited: 11
Integrated bioinformatics analysis of the effects of chronic pain on patients with spinal cord injury
Jinlong Zhang, Longju Qi, Yuyu Sun, et al.
Frontiers in Cellular Neuroscience (2025) Vol. 19
Open Access
Aberrant Subsets of Regulatory T Cells and their Correlations with Serum IL-2 in Patients with Rheumatoid Arthritis
Xiaoyu Zi, Huanhuan Yan, Baochen Li, et al.
Inflammation (2025)
Open Access
SHR-1916: A Novel PEGylated Interleukin-2 Analogue with Altered Cellular Selectivity and Improved Pharmacokinetic Profiles for Cancer Immunotherapy
Xianglin Kong, Yuan Lin, Chen Ouyang, et al.
Drug Design Development and Therapy (2025) Vol. Volume 19, pp. 1251-1270
Open Access
Cationic liposomes encapsulating IL-2 selectively induce apoptosis and significantly reduce the secretion of cytokines on M1-murine polarized macrophages
Carlos Adrián Vargas-Ángeles, Leonardo Trujillo-Cirilo, Edith Sierra-Mondragón, et al.
Cytokine (2025) Vol. 189, pp. 156903-156903
Open Access
Advancements of nanoscale drug formulations for combination treatment of colorectal cancer
Liqi Li, Maohua Chen, Rui L. Reis, et al.
International Journal of Pharmaceutics (2025), pp. 125508-125508
Closed Access
Michael Mackey and Data-Driven Models of Chemotherapy-Induced Neutropenia
Morgan Craig
Lecture notes on mathematical modelling in the life sciences (2025), pp. 9-18
Closed Access
Exploiting regulatory T cells (Tregs): Cutting-edge therapy for autoimmune diseases
Marwa Hassan, Mohamed Elzallat, Dina Mostafa Mohammed, et al.
International Immunopharmacology (2025) Vol. 155, pp. 114624-114624
Open Access
Immunotherapy for autoimmune encephalitis
Lufeng Cheng, Bingyang Jia, Chuanlei Wang, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Polypharmacological Cell-Penetrating Peptides from Venomous Marine Animals Based on Immunomodulating, Antimicrobial, and Anticancer Properties
Shiva Hemmati, Haniyeh Rasekhi Kazerooni
Marine Drugs (2022) Vol. 20, Iss. 12, pp. 763-763
Open Access | Times Cited: 17
Association of serum interleukin-2 with severity and prognosis in hospitalized patients with community-acquired pneumonia: a prospective cohort study
Feng-Min Zhu, Juan Xu, Qi-Yuan He, et al.
Internal and Emergency Medicine (2024) Vol. 19, Iss. 7, pp. 1929-1939
Open Access | Times Cited: 3
The role of interleukin (IL)-2 cytokine family in Parkinson's disease
Pouya Goleij, Afshin Amini, Mohammad Amin Khazeei Tabari, et al.
Cytokine (2025) Vol. 191, pp. 156954-156954
Closed Access
Page 1 - Next Page

Scroll to top